Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2′-deoxy-5-fluorouridine into DNA
SAKAMOTO, KAZUKI, YOKOGAWA, TATSUSHI, UENO, HIROYUKI, OGUCHI, KEI, KAZUNO, HIROMI, ISHIDA, KEIJI, TANAKA, NOZOMU, OSADA, AKIKO, YAMADA, YUKARI, OKABE, HIROYUKI, MATSUO, KENICHI
Published in International journal of oncology (01.06.2015)
Published in International journal of oncology (01.06.2015)
Get full text
Journal Article
Abstract P020: Schlafen 11 (SLFN11) as a predictive biomarker of the response to TAS1553, a novel small molecule ribonucleotide reductase subunit interaction inhibitor
Fukushima, Hiroto, Ueno, Hiroyuki, Hoshino, Takuya, Yano, Wakako, Itadani, Hiraku, Terasaka, Miki, Tsukioka, Sayaka, Suzuki, Takamasa, Hara, Shoki, Ogino, Yoshio, Chong, Khoon Tee, Suzuki, Tatsuya, Otsu, Yoshihiro, Ito, Satoshi, Tanaka, Nozomu, Miyahara, Seiji
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
Abstract C104: TAS-121, a highly potent and mutant-specific EGFR inhibitor, modulates the immune system, resulting in anti-tumor immune responses
Fukaya, Satoshi, Aoyagi, Yoshimi, Katoh, Masanori, Itoh, Kimihiro, Shibutani, Toshihiro, Tanaka, Nozomu, Haruma, Tomonori, Hashimoto, Akihiro, Miyadera, Kazutaka, Matsuo, Kenichi, Iwasawa, Yoshikazu, Utsugi, Teruhiro, Yonekura, Kazuhiko
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Abstract B86: Potent antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, on both cetuximab-sensitive KRAS wild-type and cetuximab-resistant KRAS mutated colorectal cancer cells via trifluorothymidine incorporation into DNA
Tanaka, Nozomu, Yamada, Yukari, Fujioka, Akio, Yamamura, Keisuke, Ito, Satoko, Matsuo, Kenichi, Utsugi, Teruhiro
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Abstract B87: Preclinical investigation of the potentiation in antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, in combination with irinotecan (CPT-11) in colorectal cancer
Ishida, Keiji, Tanaka, Nozomu, Tsukioka, Sayaka, Eshima, Kokoro, Fujioka, Akio, Yamamura, Keisuke, Ito, Satoko, Matsuo, Kenichi, Utsugi, Teruhiro
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Abstract 1783: Trifluorothymidine incorporation into DNA strongly enforces the potential of TAS-102 and leads to remarkably prolonged survival of cancer patients
Tanaka, Nozomu, Oguchi, Kei, Fujita, Ryoto, Suzuki, Takamasa, Yamamura, Keisuke, Fujioka, Akio, Okabe, Hiroyuki, Noguchi, Kazuharu
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article